{"id":"levamisole","rwe":[{"pmid":"41891191","year":"2026","title":"Rapid ultrasensitive detection of levamisole and mebendazole residues in meat products based on an intelligent nanozyme-imprinted fluorescence microfluidic sensor.","finding":"","journal":"Analytical methods : advancing methods and applications","studyType":"Clinical Study"},{"pmid":"41859992","year":"2026","title":"Clinical and immunological effects of Malva sylvestris and levamisole combination in the treatment of trichophytosis in cattle.","finding":"","journal":"Polish journal of veterinary sciences","studyType":"Clinical Study"},{"pmid":"41849961","year":"2026","title":"Levamisole in opioid overdose patients: An evolving adulterant landscape.","finding":"","journal":"Addictive behaviors","studyType":"Clinical Study"},{"pmid":"41849477","year":"2026","title":"Ornamental coral pests and parasites: a biosecurity alert for aquarium trade.","finding":"","journal":"Brazilian journal of biology = Revista brasleira de biologia","studyType":"Clinical Study"},{"pmid":"41819959","year":"2026","title":"Anthelmintic resistance on meat goat properties in Queensland and New South Wales, Australia, with a comparison of statistical methods.","finding":"","journal":"Veterinary parasitology, regional studies and reports","studyType":"Clinical Study"}],"tags":[{"label":"levamisole","category":"class"},{"label":"Small Molecule","category":"modality"},{"label":"Alkaline phosphatase, tissue-nonspecific isozyme","category":"target"},{"label":"ALPL","category":"gene"},{"label":"ALPI","category":"gene"},{"label":"P02CE01","category":"atc"},{"label":"Off-Patent","category":"patent"},{"label":"Active","category":"status"},{"label":"Ancylostomiasis","category":"indication"},{"label":"Ascariasis","category":"indication"},{"label":"Approved 1990s","category":"decade"},{"label":"Adjuvants, Immunologic","category":"pharmacology"},{"label":"Anthelmintics","category":"pharmacology"},{"label":"Anti-Infective Agents","category":"pharmacology"},{"label":"Antinematodal Agents","category":"pharmacology"},{"label":"Antiparasitic Agents","category":"pharmacology"},{"label":"Antirheumatic Agents","category":"pharmacology"},{"label":"Immunologic Factors","category":"pharmacology"}],"phase":"marketed","safety":{"safetySignals":[{"llr":502.109,"date":"","count":186,"signal":"Toxicity to various agents","source":"DrugCentral FAERS","actionTaken":"Reported 186 times (LLR=502)"},{"llr":304.714,"date":"","count":100,"signal":"Drug abuse","source":"DrugCentral FAERS","actionTaken":"Reported 100 times (LLR=305)"},{"llr":117.332,"date":"","count":44,"signal":"Intentional product misuse","source":"DrugCentral FAERS","actionTaken":"Reported 44 times (LLR=117)"},{"llr":114.712,"date":"","count":31,"signal":"Poisoning","source":"DrugCentral FAERS","actionTaken":"Reported 31 times (LLR=115)"}],"drugInteractions":[{"url":"/drug/phenprocoumon","drug":"phenprocoumon","action":"Monitor closely","effect":"May interact with Phenprocoumon","source":"DrugCentral","drugSlug":"phenprocoumon"},{"url":"/drug/warfarin","drug":"warfarin","action":"Monitor closely","effect":"May interact with Warfarin","source":"DrugCentral","drugSlug":"warfarin"}],"commonSideEffects":[{"effect":"Swelling at injection site","drugRate":"","severity":"common","organSystem":""},{"effect":"Hypersalivation","drugRate":"","severity":"common","organSystem":""},{"effect":"Tissue damage at injection site","drugRate":"","severity":"common","organSystem":""}],"seriousAdverseEvents":[{"effect":"Granulomas at injection site","drugRate":"","severity":"serious"},{"effect":"Necrosis at injection site","drugRate":"","severity":"serious"},{"effect":"Clostridial infection","drugRate":"","severity":"serious"},{"effect":"Death","drugRate":"","severity":"serious"}]},"trials":[],"aliases":[],"patents":[],"pricing":[],"_sources":{"trials":{"url":"https://clinicaltrials.gov/search?intr=LEVAMISOLE","method":"api_direct","source":"ClinicalTrials.gov","rawText":"","confidence":1,"sourceType":"ctgov","retrievedAt":"2026-04-20T01:51:28.300883+00:00"},"timeline":{"url":"https://en.wikipedia.org/wiki/Levamisole","method":"deterministic","source":"Wikipedia","rawText":"","confidence":0.8,"sourceType":"wikipedia","retrievedAt":"2026-04-20T01:51:35.844874+00:00"},"regulatory.ca":{"url":"","method":"api_direct","source":"Health Canada DPD","rawText":"","confidence":1,"sourceType":"health_canada_dpd","retrievedAt":"2026-04-20T01:51:34.420855+00:00"},"publicationCount":{"url":"https://pubmed.ncbi.nlm.nih.gov/?term=LEVAMISOLE","method":"api_direct","source":"PubMed/NCBI","rawText":"","confidence":1,"sourceType":"pubmed","retrievedAt":"2026-04-20T01:51:34.785494+00:00"},"crossReferences.chemblId":{"url":"https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL1454/","method":"api_direct","source":"ChEMBL (EMBL-EBI)","rawText":"","confidence":1,"sourceType":"chembl","retrievedAt":"2026-04-20T01:51:35.487233+00:00"}},"allNames":"levamisol","offLabel":[],"synonyms":["levamisole hydrochloride","levamisole","tetramisole","levamisol","levamizol","tetramisole hydrochloride","levamisole HCl","tetramisole HCl","levamisole phosphate","levamisole resinate"],"timeline":[{"date":"1990-06-18","type":"positive","source":"DrugCentral","milestone":"FDA approval"}],"aiSummary":"Levamisole is a small molecule drug in the levamisole class, originally developed by Janssen Pharmaceutica and currently owned by Johnson & Johnson. It targets the tissue-nonspecific isozyme of alkaline phosphatase and is FDA-approved for the treatment of Ancylostomiasis and Ascariasis. Levamisole is off-patent and has no active Orange Book patents, indicating that it is available as a generic medication. Despite its off-patent status, there are currently no generic manufacturers of levamisole. It has a bioavailability of 65%.","approvals":[{"date":"1990-06-18","orphan":false,"company":"","regulator":"FDA"}],"brandName":"Levamisol","ecosystem":[{"indication":"Ancylostomiasis","otherDrugs":[],"globalPrevalence":440000000},{"indication":"Ascariasis","otherDrugs":[{"name":"mebendazole","slug":"mebendazole","company":""},{"name":"piperazine","slug":"piperazine","company":"Bluline"},{"name":"thiabendazole","slug":"thiabendazole","company":""}],"globalPrevalence":null}],"mechanism":{"target":"Alkaline phosphatase, tissue-nonspecific isozyme","targets":[{"gene":"ALPL","source":"DrugCentral","target":"Alkaline phosphatase, tissue-nonspecific isozyme","protein":"Alkaline phosphatase, tissue-nonspecific isozyme"},{"gene":"ALPI","source":"DrugCentral","target":"Intestinal-type alkaline phosphatase","protein":"Intestinal-type alkaline phosphatase"}],"modality":"Small Molecule","drugClass":"levamisole","explanation":"","oneSentence":"","technicalDetail":"Levamisole acts as a nicotinic acetylcholine receptor agonist, mimicking the action of acetylcholine to stimulate muscle contraction and paralysis of the parasitic worms, ultimately leading to their expulsion from the body."},"_wikipedia":{"url":"https://en.wikipedia.org/wiki/Levamisole","title":"Levamisole","extract":"Levamisole, sold under the brand name Ergamisol among others, is a medication used to treat parasitic worm infections, specifically ascariasis and hookworm infections. It is taken by mouth."},"commercial":{"launchDate":"1990","_launchSource":"DrugCentral (FDA 1990-06-18, )"},"references":[{"id":1,"url":"https://drugcentral.org/drugcard/1561","fields":["approvals","synonyms","ATC","PK","indications","contraindications","DDIs","targets","patents","FAERS"],"source":"DrugCentral"},{"id":2,"url":"https://clinicaltrials.gov/search?intr=LEVAMISOLE","fields":["trials"],"source":"ClinicalTrials.gov"},{"id":3,"url":"https://pubmed.ncbi.nlm.nih.gov/?term=LEVAMISOLE","fields":["publications"],"source":"PubMed/NCBI"},{"id":4,"url":"https://en.wikipedia.org/wiki/Levamisole","fields":["history","overview"],"source":"Wikipedia"},{"id":5,"url":"https://www.fda.gov/drugs/drug-approvals-and-databases/orange-book-data-files","fields":["patents","exclusivity","genericManufacturers"],"source":"FDA Orange Book"}],"_enrichedAt":"2026-03-30T14:05:58.427516","_validation":{"fieldsValidated":0,"lastValidatedAt":"2026-04-20T01:51:37.058937+00:00","fieldsConflicting":2,"overallConfidence":0.8},"biosimilars":[],"competitors":[],"genericName":"levamisole","indications":{"approved":[{"name":"Ancylostomiasis","source":"DrugCentral","snomedId":63479002,"regulator":"FDA","globalPrevalence":440000000,"prevalenceMethod":"ai-extracted","prevalenceSource":"Am J Trop Med Hyg, 2020 (PMID:32342850)"},{"name":"Ascariasis","source":"DrugCentral","snomedId":2435008,"regulator":"FDA"}],"offLabel":[],"pipeline":[]},"drugCategory":"active","labelChanges":[],"patentStatus":"Off-patent — no active Orange Book patents","relatedDrugs":[],"trialDetails":[{"nctId":"NCT06907173","phase":"PHASE3","title":"Ketamine add-on Therapy for Established Status Epilepticus Treatment Trial (KESETT)","status":"RECRUITING","sponsor":"University of Virginia","startDate":"2026-02","conditions":["Status Epilepticus"],"enrollment":770,"completionDate":"2029-12"},{"nctId":"NCT02203396","phase":"PHASE2","title":"A Single-Arm Phase 2 Study With Optimized Standard Protocol for Severe Aplastic Anemia","status":"COMPLETED","sponsor":"Institute of Hematology & Blood Diseases Hospital, China","startDate":"2014-08","conditions":["Aplastic Anemia"],"enrollment":40,"completionDate":"2017-09"},{"nctId":"NCT07091175","phase":"PHASE2","title":"Dupilumab Therapy in Nephrotic Syndrome in Children","status":"RECRUITING","sponsor":"National University Hospital, Singapore","startDate":"2025-11-27","conditions":["Nephrotic Syndrome in Children","Nephrotic Syndrome Steroid-Dependent"],"enrollment":66,"completionDate":"2028-02-28"},{"nctId":"NCT06252961","phase":"PHASE2,PHASE3","title":"A 3- to 5-day Clinical Trial of Levamisole in Loiasis Infected Subjects","status":"RECRUITING","sponsor":"Programme National de Lutte contre l'Onchocercose, Republic of the Congo","startDate":"2024-06-21","conditions":["Loiasis"],"enrollment":99,"completionDate":"2026-02-01"},{"nctId":"NCT05772871","phase":"PHASE4","title":"The Efficacy and Safety of Prednisone Combined With Huaiqihuang Granule for Primary Nephrotic Syndrome in Children","status":"RECRUITING","sponsor":"Jianhua Zhou","startDate":"2023-04-26","conditions":["Nephrotic Syndrome in Children"],"enrollment":402,"completionDate":"2025-10-30"},{"nctId":"NCT05889936","phase":"NA","title":"A Transdiagnostic Intervention for Health-related Habits (LEV)","status":"COMPLETED","sponsor":"Region Stockholm","startDate":"2023-01-25","conditions":["Intervention","Life Style","Health-Related Behavior","Feasibility","Quality of Life","Disabilities Physical","Disability Physical","Mental Health Wellness"],"enrollment":36,"completionDate":"2023-12-21"},{"nctId":"NCT04559529","phase":"PHASE2","title":"Pharmacological Modulation of Hippocampal Activity in Psychosis 2","status":"COMPLETED","sponsor":"Vanderbilt University Medical Center","startDate":"2020-09-23","conditions":["Schizophrenia; Psychosis"],"enrollment":62,"completionDate":"2023-12-31"},{"nctId":"NCT02818738","phase":"PHASE3","title":"Efficiency of Levamisole for Maintaining Remission After the First Flare of Steroid Sensitive Nephrotic Syndrome in Children","status":"COMPLETED","sponsor":"Assistance Publique - Hôpitaux de Paris","startDate":"2017-09-06","conditions":["First Manifestation of Steroid Sensitive Nephrotic Syndrome"],"enrollment":86,"completionDate":"2021-02-11"},{"nctId":"NCT02366884","phase":"PHASE2","title":"Clinical Evaluation of a New Form of Cancer Therapy (Atavistic Chemotherapy) Based on the Principles of Atavistic Metamorphosis (2011)","status":"UNKNOWN","sponsor":"Dr. Frank Arguello Cancer Clinic","startDate":"2011-07-26","conditions":["Neoplasms"],"enrollment":250,"completionDate":"2023-12-31"},{"nctId":"NCT04049630","phase":"PHASE2","title":"Clinical Trial Evaluating the Safety and Efficacy of Levamisole in Loa Loa Microfilaremic Patients","status":"COMPLETED","sponsor":"Programme National de Lutte contre l'Onchocercose, Republic of the Congo","startDate":"2021-01-16","conditions":["Onchocerciasis, Ocular","Loiasis"],"enrollment":255,"completionDate":"2021-07-15"},{"nctId":"NCT04611373","phase":"PHASE3","title":"Clinical Study on the Efficacy of Acetazolamide Combined With Levamisole in the Treatment of HCC","status":"UNKNOWN","sponsor":"The First Affiliated Hospital of Zhengzhou University","startDate":"2020-05-01","conditions":["HCC"],"enrollment":50,"completionDate":"2021-05-31"},{"nctId":"NCT04383717","phase":"PHASE3","title":"Levamisole and Isoprinosine in the Treatment of COVID19: A Proposed Therapeutic Trial","status":"UNKNOWN","sponsor":"Cairo University","startDate":"2020-05-05","conditions":["Respiratory Tract Infections"],"enrollment":60,"completionDate":"2020-10-30"},{"nctId":"NCT04360122","phase":"PHASE3","title":"Levamisole and Isoprinosine in Immune-prophylaxis of Egyptian Healthcare Workers Facing COVID-19","status":"UNKNOWN","sponsor":"Ain Shams University","startDate":"2020-05-20","conditions":["Coronavirus Disease (COVID-19)"],"enrollment":100,"completionDate":"2020-12-01"},{"nctId":"NCT04331470","phase":"PHASE2,PHASE3","title":"Evaluation of Efficacy of Levamisole and Formoterol+Budesonide in Treatment of COVID-19","status":"UNKNOWN","sponsor":"Fasa University of Medical Sciences","startDate":"2020-04-04","conditions":["COVID-19"],"enrollment":30,"completionDate":"2020-05-20"},{"nctId":"NCT03950518","phase":"PHASE3","title":"Novel Treatment of Advanced Hepatocellular Carcinoma","status":"UNKNOWN","sponsor":"The First Affiliated Hospital of Zhengzhou University","startDate":"2019-04-10","conditions":["HCC"],"enrollment":300,"completionDate":"2023-04-10"},{"nctId":"NCT03940378","phase":"PHASE3","title":"Treatment of Advanced Intrahepatic Cholangiocarcinoma","status":"UNKNOWN","sponsor":"The First Affiliated Hospital of Zhengzhou University","startDate":"2019-02-01","conditions":["ICC"],"enrollment":152,"completionDate":"2023-02-01"},{"nctId":"NCT03218657","phase":"NA","title":"Clinical Study of Non Severe Aplastic Anemia Treated With Cyclosporine, Androgen and Levamisole","status":"UNKNOWN","sponsor":"Shengyun Lin","startDate":"2018-01-01","conditions":["Aplastic Anemia"],"enrollment":248,"completionDate":"2022-07-01"},{"nctId":"NCT01383941","phase":"","title":"Asthma Phenotypes in the Inner City","status":"COMPLETED","sponsor":"National Institute of Allergy and Infectious Diseases (NIAID)","startDate":"2011-08","conditions":["Asthma","Rhinitis"],"enrollment":717,"completionDate":"2014-09"},{"nctId":"NCT00003063","phase":"PHASE3","title":"Biological Therapy With Combination Chemotherapy in Patients With Colorectal Cancer","status":"UNKNOWN","sponsor":"European Institute of Oncology","startDate":"1991-11","conditions":["Colorectal Cancer"],"enrollment":1050,"completionDate":""},{"nctId":"NCT00705692","phase":"PHASE2","title":"Effect of Levamisole Supplementation on Tetanus Vaccination Response Rates in Hemodialysis Patients","status":"COMPLETED","sponsor":"Shiraz University of Medical Sciences","startDate":"2008-03","conditions":["Renal Dialysis"],"enrollment":40,"completionDate":"2008-11"},{"nctId":"NCT00002551","phase":"PHASE3","title":"SWOG-9304 Chemotherapy Plus Radiation Therapy in Treating Patients With Rectal Cancer That Has Been Surgically Removed","status":"COMPLETED","sponsor":"SWOG Cancer Research Network","startDate":"1994-03","conditions":["Colorectal Cancer"],"enrollment":1917,"completionDate":"2008-10"},{"nctId":"NCT01760096","phase":"PHASE2","title":"Safety and Efficacy of Levamisole Combined With Cyclosporine A in Patients With Subclinical Paroxysmal Nocturnal Hemoglobinuria and PNH in the Setting of Another Bone Marrow Failure Syndromes(PNH-2013)","status":"UNKNOWN","sponsor":"Institute of Hematology & Blood Diseases Hospital, China","startDate":"2013-01","conditions":["Paroxysmal Nocturnal Hemoglobinuria","Hemoglobinuria","Hemoglobinuria, Paroxysmal","Proteinuria","Urination Disorders","Thrombosis","Bone Marrow Failure","Aplastic Anemia,","Anemia, Hemolytic"],"enrollment":50,"completionDate":"2017-07"},{"nctId":"NCT00002593","phase":"PHASE3","title":"S9415 Chemotherapy in Patients With Stage II or III Colon Cancer That Has Been Surgically Removed","status":"COMPLETED","sponsor":"SWOG Cancer Research Network","startDate":"1994-12","conditions":["Colorectal Cancer"],"enrollment":1135,"completionDate":"2005-03"},{"nctId":"NCT01642979","phase":"PHASE2","title":"Safety and Efficacy of Levamisole Combined With Cyclosporine A in Patients With Classic Paroxysmal Nocturnal Hemoglobinuria","status":"UNKNOWN","sponsor":"Institute of Hematology & Blood Diseases Hospital, China","startDate":"2012-07","conditions":["Paroxysmal Nocturnal Hemoglobinuria","Hemoglobinuria","Hemoglobinuria, Paroxysmal","Proteinuria","Urination Disorders","Thrombosis","Bone Marrow Failure","Aplastic Anemia,","Anemia, Hemolytic"],"enrollment":120,"completionDate":"2017-07"},{"nctId":"NCT01579110","phase":"PHASE2","title":"Efficacy and Safety of Levamisole Combined With Standard Prednisolone in Warm Antibody Autoimmune Hemolytic Anemia.","status":"UNKNOWN","sponsor":"Institute of Hematology & Blood Diseases Hospital, China","startDate":"2012-04","conditions":["Anemia","Anemia, Hemolytic","Anemia, Hemolytic, Autoimmune","Hemolysis","Hematologic Diseases","Autoimmune Diseases","Immune System Diseases","Pathologic Processes"],"enrollment":100,"completionDate":"2016-04"},{"nctId":"NCT01348321","phase":"PHASE2,PHASE3","title":"Comparison of Efficacy of Azithromycin and Levamisole Versus of Azithromycin in in the Treatment of Acne","status":"COMPLETED","sponsor":"Ahvaz Jundishapur University of Medical Sciences","startDate":"2008-11","conditions":["Acne"],"enrollment":169,"completionDate":"2009-10"},{"nctId":"NCT00425152","phase":"PHASE3","title":"Fluorouracil and Leucovorin and/or Levamisole After Surgery In Treating Patients With Dukes' B Or Dukes' C Colon Cancer","status":"COMPLETED","sponsor":"NSABP Foundation Inc","startDate":"1989-07","conditions":["Colorectal Cancer"],"enrollment":2151,"completionDate":"2004-04"},{"nctId":"NCT00659997","phase":"PHASE4","title":"Efficacy Albendazole and Levamisole Against STH on Unguja","status":"COMPLETED","sponsor":"Natural History Museum, United Kingdom","startDate":"2006-06","conditions":["Ascariasis","Trichuriasis"],"enrollment":20,"completionDate":"2007-09"},{"nctId":"NCT00309530","phase":"PHASE3","title":"Randomized Study on Adjuvant Chemotherapy and Adjuvant Chemo-Immunotherapy in Colon Carcinoma Dukes C","status":"COMPLETED","sponsor":"Austrian Breast & Colorectal Cancer Study Group","startDate":"1990-10","conditions":["Colon Cancer Stage III"],"enrollment":598,"completionDate":""}],"genericFilers":[],"latestUpdates":[],"manufacturing":[],"_patentsChecked":true,"crossReferences":{"MMSL":"4967","NDDF":"003546","UNII":"2880D3468G","CHEBI":"CHEBI:6432","VANDF":"4019531","INN_ID":"2643","RXNORM":"1535214","UMLSCUI":"C0023556","chemblId":"CHEMBL1454","ChEMBL_ID":"CHEMBL1454","KEGG_DRUG":"D00750","DRUGBANK_ID":"DB00848","PUBCHEM_CID":"26879","SNOMEDCT_US":"387296006","IUPHAR_LIGAND_ID":"7210","SECONDARY_CAS_RN":"16595-80-5","MESH_DESCRIPTOR_UI":"D007978"},"formularyStatus":[],"_enricherVersion":"v2","developmentCodes":[],"ownershipHistory":[],"pharmacokinetics":{"source":"DrugCentral","bioavailability":"65%"},"publicationCount":5098,"therapeuticAreas":["Other"],"atcClassification":{"source":"DrugCentral","atcCode":"P02CE01","allCodes":["P02CE01"]},"biosimilarFilings":[],"recentPublications":[{"date":"2026 Mar 27","pmid":"41891191","title":"Rapid ultrasensitive detection of levamisole and mebendazole residues in meat products based on an intelligent nanozyme-imprinted fluorescence microfluidic sensor.","journal":"Analytical methods : advancing methods and applications"},{"date":"2026","pmid":"41859992","title":"Clinical and immunological effects of Malva sylvestris and levamisole combination in the treatment of trichophytosis in cattle.","journal":"Polish journal of veterinary sciences"},{"date":"2026 Mar 14","pmid":"41849961","title":"Levamisole in opioid overdose patients: An evolving adulterant landscape.","journal":"Addictive behaviors"},{"date":"2026","pmid":"41849477","title":"Ornamental coral pests and parasites: a biosecurity alert for aquarium trade.","journal":"Brazilian journal of biology = Revista brasleira de biologia"},{"date":"2026 Apr","pmid":"41819959","title":"Anthelmintic resistance on meat goat properties in Queensland and New South Wales, Australia, with a comparison of statistical methods.","journal":"Veterinary parasitology, regional studies and reports"}],"companionDiagnostics":[],"genericManufacturers":0,"_genericFilersChecked":true,"genericManufacturerList":[],"status":"withdrawn","companyName":"","companyId":"","modality":"Small molecule","firstApprovalDate":"1990","enrichmentLevel":3,"visitCount":0,"regulatoryByCountry":[{"country_code":"US","regulator":"FDA","status":"approved","approval_date":"1990-06-18T00:00:00.000Z","mah":"","brand_name_local":null,"application_number":""},{"country_code":"CA","regulator":"Health Canada","status":"approved","approval_date":null,"mah":"","brand_name_local":"","application_number":""},{"country_code":"IL","regulator":"MOH","status":"likely_approved","approval_date":null,"mah":null,"brand_name_local":null,"application_number":null},{"country_code":"SG","regulator":"HSA","status":"likely_approved","approval_date":null,"mah":null,"brand_name_local":null,"application_number":null},{"country_code":"AE","regulator":"MOH","status":"likely_approved","approval_date":null,"mah":null,"brand_name_local":null,"application_number":null},{"country_code":"KR","regulator":"MFDS","status":"likely_approved","approval_date":null,"mah":null,"brand_name_local":null,"application_number":null},{"country_code":"AU","regulator":"TGA","status":"likely_approved","approval_date":null,"mah":null,"brand_name_local":null,"application_number":null},{"country_code":"GB","regulator":"MHRA","status":"likely_approved","approval_date":null,"mah":null,"brand_name_local":null,"application_number":null}],"trialStats":{"total":0,"withResults":0},"validation":{"fieldsValidated":0,"lastValidatedAt":"2026-04-20T01:51:37.058937+00:00","fieldsConflicting":2,"overallConfidence":0.8},"verificationStatus":"verified","dataCompleteness":{"mechanism":false,"indications":true,"safety":true,"trials":true,"score":3}}